<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-08T11:18:10+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Science子刊：iPSC来源NK细胞联合PD-1抗体显示出强大的抗肿瘤活性｜医麦猛爆料</title>
    <updated>2020-11-08T09:10:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/zBI-2R_VltcicE0mKiX4dg</id>
    <link href="https://mp.weixin.qq.com/s/zBI-2R_VltcicE0mKiX4dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」百奥泰资深副总裁冉兆祥：新药赛道愈发拥挤，适者生存是永恒法则</title>
    <updated>2020-11-08T09:10:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/zyOGcyalLt4O7dPKIgFhDg</id>
    <link href="https://mp.weixin.qq.com/s/zyOGcyalLt4O7dPKIgFhDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以红细胞作为全新起点，向肿瘤发起进攻！医麦猛爆料</title>
    <updated>2020-11-07T09:11:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/Y4uXbTTUL-lOeOKxx9EjJQ</id>
    <link href="https://mp.weixin.qq.com/s/Y4uXbTTUL-lOeOKxx9EjJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020摘选：两款新靶点CAR-T，有效性、安全性和低成本全都要！丨医麦猛爆料</title>
    <updated>2020-11-07T09:11:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/VeU058GUFUQ6V6FRWIdyFA</id>
    <link href="https://mp.weixin.qq.com/s/VeU058GUFUQ6V6FRWIdyFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CD20 CAR-T产品获得受理，CD20潜力无限丨医麦猛爆料</title>
    <updated>2020-11-07T09:11:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/k81kAWDLdydo5-eQZ-45RA</id>
    <link href="https://mp.weixin.qq.com/s/k81kAWDLdydo5-eQZ-45RA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物宣布将在2020年美国血液病学会 (ASH) 年会暨展览会上发表两份口头报告丨医麦猛爆料</title>
    <updated>2020-11-06T09:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/549rYekcs6v8g52EX8x8GA</id>
    <link href="https://mp.weixin.qq.com/s/549rYekcs6v8g52EX8x8GA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>27.5亿美元！MSD买下VelosBio公司，获得ROR1 ADC药物再次扩大肿瘤治疗产品管线丨医麦新观察</title>
    <updated>2020-11-06T09:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/lTZiW5lGzFb1S6uXo2OOGA</id>
    <link href="https://mp.weixin.qq.com/s/lTZiW5lGzFb1S6uXo2OOGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020精选：国外CAR-T的研究进展，值得一看丨医麦新观察</title>
    <updated>2020-11-06T09:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/GB_ZRu1lK1tT0hvnpsbApA</id>
    <link href="https://mp.weixin.qq.com/s/GB_ZRu1lK1tT0hvnpsbApA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA疫苗研发，这些技术挑战你解决了吗？丨医麦新观察</title>
    <updated>2020-11-05T15:21:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/gzM8bjidi0TNHHZLIKT8pg</id>
    <link href="https://mp.weixin.qq.com/s/gzM8bjidi0TNHHZLIKT8pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药前辈丨养生堂生物医药诚聘海内外博士，五大平台，10+岗位，提供行业内TOP薪资！</title>
    <updated>2020-11-05T15:21:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/VKzU_PgAJfB1RJ8G113wPA</id>
    <link href="https://mp.weixin.qq.com/s/VKzU_PgAJfB1RJ8G113wPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 BPID精彩回顾丨第三届生物创新药临床前研究与临床申报峰会圆满落幕！</title>
    <updated>2020-11-05T15:21:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/qhgAuiNa944_o4YKDqP_sw</id>
    <link href="https://mp.weixin.qq.com/s/qhgAuiNa944_o4YKDqP_sw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 BPID精彩回顾丨医麦客2020(第二届)全球生物药CDMO发展高峰论坛圆满落幕！</title>
    <updated>2020-11-04T22:22:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/v385gAKxmnSPsdXFeOf91A</id>
    <link href="https://mp.weixin.qq.com/s/v385gAKxmnSPsdXFeOf91A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年国自然基金标书构思及撰写经验分享会(11.14-15 网络精讲班)</title>
    <updated>2020-11-04T22:22:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/lCc13s8CzvpjOGifjj1YKA</id>
    <link href="https://mp.weixin.qq.com/s/lCc13s8CzvpjOGifjj1YKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>视频花絮丨2020 BPID生物药产业发展大会</title>
    <updated>2020-11-04T22:22:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/odbpuWT6qdbAuJeWIDTU9A</id>
    <link href="https://mp.weixin.qq.com/s/odbpuWT6qdbAuJeWIDTU9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>与“旎”共话实体瘤新型疗法的未来！</title>
    <updated>2020-11-04T22:22:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/kH9IvDE9_2B86ykNB_hlfg</id>
    <link href="https://mp.weixin.qq.com/s/kH9IvDE9_2B86ykNB_hlfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 BPID精彩回顾丨开幕式暨第二届星耀榜颁奖典礼</title>
    <updated>2020-11-03T13:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/g09IQec4vAwLt7ki8bJbQQ</id>
    <link href="https://mp.weixin.qq.com/s/g09IQec4vAwLt7ki8bJbQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生动细胞 &amp; 深研生物丨邀您参加2020BPID生物药产业发展大会</title>
    <updated>2020-11-03T13:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/X_m6w6tMQrXGMpbyue6uNg</id>
    <link href="https://mp.weixin.qq.com/s/X_m6w6tMQrXGMpbyue6uNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」宇繁生物总经理王瑜：预计HPK1将成为下一个PD-1，全球首个敲除HPK1的CAR-T临床研究正在进行中</title>
    <updated>2020-11-03T13:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/TdOLKdcdIeQSC2okL2y1xA</id>
    <link href="https://mp.weixin.qq.com/s/TdOLKdcdIeQSC2okL2y1xA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾生物基因与细胞治疗CDMO平台启动，全面提升工艺研发与商业化生产能力，争当国内领先国际一流丨医麦猛爆料</title>
    <updated>2020-11-02T22:51:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/bfV40Ozp10jAN6x9jrnFYQ</id>
    <link href="https://mp.weixin.qq.com/s/bfV40Ozp10jAN6x9jrnFYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>告别昂贵的单细胞测序， 挖掘公共数据库的单细胞测序数据， 不需做实验发表文章（11.7-8 网络精讲班）</title>
    <updated>2020-11-02T22:51:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/NdaBJeCaQV-A3cEjf8T-jA</id>
    <link href="https://mp.weixin.qq.com/s/NdaBJeCaQV-A3cEjf8T-jA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>